Spero Therapeutics, Inc. Shares Outstanding (Cover Page)
Spero Therapeutics, Inc. (SPRO) had Shares Outstanding (Cover Page) of 58.23 million shares as of 2026-08-07, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-07: Entity Common Stock, Shares Outstanding 58.23M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 57.90M shares.
- 2026-03-20: Entity Common Stock, Shares Outstanding 57.89M shares.
- 2025-11-06: Entity Common Stock, Shares Outstanding 56.34M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-07 | 58.23M shares 10-Q · filed 2026-08-12 |
| 2026-05-01 | 57.90M shares 10-Q · filed 2026-05-13 |
| 2026-03-20 | 57.89M shares 10-K · filed 2026-03-26 |
| 2025-11-06 | 56.34M shares 10-Q · filed 2025-11-13 |
| 2025-08-05 | 56.28M shares 10-Q · filed 2025-08-12 |
| 2025-05-01 | 55.91M shares 10-Q · filed 2025-05-13 |
| 2025-03-21 | 55.90M shares 10-K · filed 2025-03-27 |
| 2024-11-06 | 54.52M shares 10-Q · filed 2024-11-14 |
| 2024-08-01 | 54.05M shares 10-Q · filed 2024-08-05 |
| 2024-05-06 | 53.99M shares 10-Q · filed 2024-05-15 |
| 2024-03-08 | 53.87M shares 10-K · filed 2024-03-13 |
| 2023-11-06 | 53.00M shares 10-Q · filed 2023-11-13 |
| 2023-08-04 | 52.70M shares 10-Q · filed 2023-08-10 |
| 2023-05-01 | 52.57M shares 10-Q · filed 2023-05-11 |
| 2023-03-01 | 52.57M shares 10-K · filed 2023-03-30 |
| 2022-11-10 | 51.78M shares 10-Q · filed 2022-11-14 |
| 2022-08-05 | 35.07M shares 10-Q · filed 2022-08-10 |
| 2022-05-12 | 32.82M shares 10-Q · filed 2022-05-16 |
| 2022-03-25 | 32.76M shares 10-K · filed 2022-03-31 |
| 2021-11-05 | 32.32M shares 10-Q · filed 2021-11-10 |
| 2021-07-29 | 32.15M shares 10-Q · filed 2021-08-05 |
| 2021-04-29 | 29.67M shares 10-Q · filed 2021-05-06 |
| 2021-03-08 | 29.50M shares 10-K · filed 2021-03-11 |
| 2020-10-29 | 27.19M shares 10-Q · filed 2020-11-05 |
| 2020-07-30 | 21.15M shares 10-Q · filed 2020-08-06 |
| 2020-05-01 | 20.60M shares 10-Q · filed 2020-05-08 |
| 2020-03-09 | 20.33M shares 10-K · filed 2020-03-16 |
| 2019-10-31 | 19.13M shares 10-Q · filed 2019-11-04 |
| 2019-08-05 | 18.66M shares 10-Q · filed 2019-08-08 |
| 2019-05-06 | 17.52M shares 10-Q · filed 2019-05-09 |
| 2019-03-08 | 17.22M shares 10-K · filed 2019-03-14 |
| 2018-11-05 | 18.19M shares 10-Q · filed 2018-11-08 |
| 2018-08-06 | 18.17M shares 10-Q · filed 2018-08-09 |
| 2018-05-07 | 14.38M shares 10-Q · filed 2018-05-10 |
| 2018-03-28 | 14.37M shares 10-K · filed 2018-04-02 |
| 2017-11-30 | 14.37M shares 10-Q · filed 2017-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |